As of Feb 24
| +0.20 / +3.55%|
The 8 analysts offering 12-month price forecasts for TherapeuticsMD Inc have a median target of 17.25, with a high estimate of 34.00 and a low estimate of 12.00. The median estimate represents a +195.38% increase from the last price of 5.84.
The current consensus among 8 polled investment analysts is to Buy stock in TherapeuticsMD Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.